Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2007
03/21/2007CN1305866C Method of extracting phenolic components from chinese medicine red sage root and its freeze dried powder injection agent
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
03/21/2007CN1305845C Anhydrous tiopronin natrium for curing acute or chronic liver disease and preparation method
03/21/2007CN1305530C Anti-caries oral compositions
03/21/2007CN1305527C Vaccine for treating hepatitis B, and its preparation. method
03/21/2007CN1305511C Ginseng-poria cocos oral administration liquid and its preparing method
03/21/2007CN1305509C Medicine composition for treating labyrinthine syndrome and its preparation method
03/21/2007CN1305504C Medicine for treating hepatitis
03/21/2007CN1305497C Chinese medicine plaster for enhancing body resistance and its preparation
03/21/2007CN1305491C Chinese medicinal composition for treating irritable bowel syndrome and its preparation method
03/21/2007CN1305488C Ginseng and aconite preparation for treating qi vacuity and yang desertion and its preparation method
03/21/2007CN1305468C Bolengsu compound and its preparation, medicine composition and use
03/21/2007CN1305463C Ginseng and aconite spraying agent for treating qi vacuity and yang desertion and its preparation method
03/21/2007CN1305384C Cheese capable of disinfecting helicobacter pylori
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7193072 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of bacterial infections in swine
03/20/2007US7193033 Peptide having appetite stimulating activity
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007US7192978 Pyrrolidinium derivatives
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007US7192970 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
03/20/2007US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192960 Sodium channel blockers
03/20/2007US7192959 Sodium channel blockers
03/20/2007US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192940 Ether compounds
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
03/20/2007US7192582 Human monoclonal antibodies to FC alpha receptor (CD89)
03/20/2007US7192581 Lactobacillus reuteri useful as probiotics
03/20/2007US7192570 Compositions of somatostatin analogues
03/20/2007CA2315115C Compositions of microspheres for wound healing
03/16/2007CA2520178A1 Probiotic compounds derived from lactobacillus casei strain ke01
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029760A1 Pharmaceutical for use in prevention and/or treatment of bowel disease
03/15/2007WO2006133941A3 Cannabinoid active pharmaceutical ingredient for improved dosage forms
03/15/2007WO2006121422A3 Antibodies against clostridium difficile toxins and uses thereof
03/15/2007US20070060647 Gene expression regulating agent
03/15/2007US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060568 5HT2c receptor modulators
03/15/2007US20070060556 Barium salt of benzimidazole derivative
03/15/2007US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
03/15/2007US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
03/15/2007US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
03/15/2007US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
03/15/2007US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
03/15/2007US20070059400 Composition containing ground lotus and/or lotus extract and lactic acid bacterium
03/15/2007US20070059305 Neutralizing human anti-IGFR antibody
03/15/2007US20070059292 Use of enterococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
03/15/2007US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent
03/15/2007CA2621470A1 Bicyclic aromatic substituted pyridone derivative
03/14/2007EP1762271A2 Rehydration composition
03/14/2007EP1762249A2 Freeze-dried pantoprazole preparation and pantoprazole injection
03/14/2007EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5
03/14/2007EP1761273A1 Treatment of non alcoholic steatotic hepatitis (nash)
03/14/2007EP1761271A1 Blackberry extract
03/14/2007EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/14/2007EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same
03/14/2007EP1465629B1 5-ht3 receptor antagonists and methods of use
03/14/2007EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
03/14/2007EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/14/2007EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
03/14/2007CN2877688Y Glycyrrhetic acid kali salt thin film coating tablet
03/14/2007CN1930282A Novel lactic acid bacterium
03/14/2007CN1930126A 吡啶酮衍生物 Pyridine derivatives
03/14/2007CN1929838A Solid pharmaceutical preparation containing sparingly water-soluble drug
03/14/2007CN1929828A Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic deseases
03/14/2007CN1928055A Health care wine brewing from Chinese medicinal herb barm and brewing method thereof
03/14/2007CN1927873A Method of comprehensive utilizing schisandra fruit
03/14/2007CN1927854A Preparation method of potassium sodium dehydroandroan drographolide succinate, potassium sodium dehydroandroan drographolide succinate preparation and preparation method thereof
03/14/2007CN1927399A Application of non-nucleoside virus reverse transcriptase inhibiting compound and derivative thereof for anti-hepatitis B virus purpose
03/14/2007CN1927394A Oral administration recombinant helicobacterpylori vaccine and preparing method thereof
03/14/2007CN1927382A Analgesic gastric medicated wine and preparing process thereof
03/14/2007CN1927377A Antidiarrheal wiping powder and preparing process thereof
03/14/2007CN1927376A Small thorowax droplet and preparation method thereof
03/14/2007CN1927375A Traditional Chinese medicine preparation for heat-clearing, dampness-removing, diuresis and stone removing and its preparation
03/14/2007CN1927374A Traditional Chinese medicine for treating hepatitis B and its preparing process
03/14/2007CN1927373A Health care traditional Chinese medicine formulation for conditioning functional activities of qi
03/14/2007CN1927366A Traditional Chinese medicine composition for treating chronic enterogastritis
03/14/2007CN1927365A Traditional Chinese medicine composition for treating diarrhea
03/14/2007CN1927362A Traditional Chinese powder medicine for treating toothache
03/14/2007CN1927361A Nutritious health food for protecting liver and neutralizing the effect of alcohol and its preparation
03/14/2007CN1927311A Drug for treating chronic atrophic gastritis precancerous lesion and finished capsule product thereof
03/14/2007CN1927298A Traditional Chinese medicine preparation for treating stomach and intestinal disease and its preparation
03/14/2007CN1927297A Compound recipe gallstone direct dissolution agent and its preparing process
03/14/2007CN1927284A Pharmaceutical formulation for treating chronic bacterial infection and method of prepn. of the same
03/14/2007CN1927272A Medicament for animals with heat clearing and detoxicating, detumescence and obstruction removing functions and preparing method thereof
03/14/2007CN1927270A Production process of five-ester droplet